More #UKSACT2024 reflections.
Non-university requirements to do jobs are increasingly common. SACT passport, AOS passport etc for nurses.
Yet B5 nurses remains the norm for administration of chemo.
I can't understand why these requirements cannot be mapped to appropriate AfC band...
At least 2 of the sessions at #UKSACT2024 mention our under documentation of adverse events and mention the Yellow Card Scheme.
26 years ago, my final year dissertation was titled something like "30 years on the Yellow Card Scheme, Past, Present and Future"
yellowcard.mhra.gov.uk/
🧵👇🏻
I think this is abstract Anna OB was referring to: a well placed question just as useful as a set of blood tests for detecting cardiomyopathies #UKSACT2024
She suggested a baseline set of cardio markers and then repeat only if symptoms
ESC ♥️ guidelines available as App. Discussed at #UKSACT2024
www.escardio.org/Guidelines/C...
Noted that monitoring recommendations are per SmPC which is probably more intense than 🇬🇧 👨🏻⚕️ generally think necessary/achievable
#UKSACT2024
OK my thoughts from this morning while my 📲 was under a 🪑
National -
🔖Standardised Protocols
🔖Hypersensitivity Guidelines
#UKSACT2024
Hope Vs Worry
Anna Olsen Brown describes the balance of risk Vs benefit
#UKSACT2024
Data on toxicity is lacking
SACT v4 in England seeking opinions currently - they have some (but not the right) toxicity data ... Use your voices ..
#UKSACT2024
Discussion on cost of managing toxicity not being taken into account through NICE appraisal.
Interestingly... ...I suspect if your drug SAVED on toxicity management you WOULD model the saving.
#UKSACT2024
With all these differences in configuration in AOS service etc.
Is it time to bring back Peer Review?
#UKSACT2024
I didn't fall asleep earlier. I dropped my phone and couldn't retrieve it immediately.
Will post thoughts on Hypersensitivity and Standardised Protocols later
UKONS & Macmillan have Knowledge & Skills Guidance for AOS - at various levels of practice.
I'm wondering how @bopa.org.uk build that into any future RPharmS type specialist curriculum.
© issue? But signposting of example of evidence perhaps?
#UKSACT2024
Slide showing disparities of AOS services across country from SAMBA22 audit
#UKSACT2024
Most hospitals have an AOS, but the actual delivery is varied.
Workforce, Job Plans, Guidance etc.
Even well designed services 10y ago may be out dated as Tx has changed.
Slide describing Acute Oncology Patients - new cancer diagnosis - toxicity - cancer related symptoms
#UKSACT2024
Kate Young describing Acute oncology - unplanned cancer related events.
Type 1- 3 patients. new diagnosis, Tx complications, Dx complications
To respond to the off patent question posed to James Richardson - Scotland has this, please reach out www.healthcareimprovementscotland.scot/clinical-gui... #UKSACT2024
Tom Roques with slide predicting future cancer drug spend
#UKSACT2024 Tom Roques showing global predicted costs of SACT are predicted to nearly double
Costs ignore delivery costs.
Emma Kipps with slide about real-world outcomes
#UKSACT2024
Emma Kipps explaining that SACT dataset being used to assess outcomes of CDF exiting drugs.
We need to find a BETTER way to do this for ALL outcomes.
James Richardson with slide outlining criteria to allow individual indication drug pricing
Slide showing why different pricing might be needed to get more access to the market for more indications
#UKSACT2024
James Richardson now outlining how drugs can be introduced with different drug pricing for different indications.
Slide with link to register as stakeholder
#UKSACT2024
Ann Rigg telling us 16% increase in SACT activity in last 5 years.
New service specification coming (11 years since the last draft)
Register as a stakeholder to be consulted on it
It looks like we are using #UKSACT2024 ...
